For: | Huang F, Gao J. Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy. World J Gastroenterol 2020; 26(7): 749-758 [PMID: 32116422 DOI: 10.3748/wjg.v26.i7.749] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v26/i7/749.htm |
Number | Citing Articles |
1 |
南秋 刘. Progress on Factors Affecting the Recurrence and Prognosis of Hepatocellular Carcinoma after Resection. Advances in Clinical Medicine 2022; 12(03): 1663 doi: 10.12677/ACM.2022.123239
|
2 |
YouShun Liu, Cong Cheng, HuaBang Zhou, ShouZi Hu, Hao Wang, QiaoHua Xie, LiPing Lei, Peng Wang, GuoFang Liu, HePing Hu. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization. Bulletin du Cancer 2021; 108(10): 931 doi: 10.1016/j.bulcan.2021.04.017
|
3 |
Qing Pang, Shuai Zhou, Shuangchi Liu, Huichun Liu, Zheng Lu. Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: a systematic review and meta-analysis. Updates in Surgery 2022; 74(3): 821 doi: 10.1007/s13304-021-01080-w
|
4 |
Ziwei Guo, Jun Liang. Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 869 doi: 10.2147/JHC.S360871
|
5 |
Ou Ying Yan, Hai Bo Teng, Sheng Nan Fu, Yan Zhu Chen, Feng Liu. Temporal Muscle Thickness is an Independent Prognostic Biomarker in Patients with Glioma: Analysis of 261 Cases. Cancer Management and Research 2021; : 6621 doi: 10.2147/CMAR.S326232
|
6 |
Lining Xu, Weiyu Wang, Yingying Xu. A new risk calculation model for complications of hepatectomy in adults over 75. Perioperative Medicine 2024; 13(1) doi: 10.1186/s13741-024-00366-y
|
7 |
Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu. Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers. Diagnostics 2023; 13(8): 1442 doi: 10.3390/diagnostics13081442
|
8 |
Lei Zhao, Nijia Chang, Lei Shi, Fengyi Li, Fanglin Meng, Xiaohui Xie, Zhe Xu, Fusheng Wang. Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study. Heliyon 2022; 8(6): e09538 doi: 10.1016/j.heliyon.2022.e09538
|
9 |
Ziyu Xun, Yanyu Wang, Junyu Long, Yiran Li, Xu Yang, Huishan Sun, Haitao Zhao. Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma. Frontiers in Genetics 2023; 13 doi: 10.3389/fgene.2022.1034979
|
10 |
Lining Xu, Yingying Xu, Guiping Li, Bo Yang. Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00896-5
|